IP Library Granted Patent US 10,888,455
Granted Patent B2
US 10,888,455 · App. 16/381,123 · Granted Jan 12, 2021

Image-guided delivery of ophthalmic therapeutics

Inventors: Sunil K. Srivastava (Shaker Heights, OH); Justis P. Ehlers (Shaker Hts., OH); Yuankai K. Tao (Shaker Hts., OH)
Assignee: THE CLEVELAND CLINIC FOUNDATION
A61F9/0017A61B3/102A61F9/0026G16H10/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,888,455
App. No.
16/381,123
Granted
Jan 12, 2021
Kind
B2
Abstract

Systems and methods are provided for image-guided delivery of therapeutics to an eye. An optical coherence tomography (OCT) imager is configured to produce at least one OCT image of the eye. A therapeutic delivery system is configured to deliver a therapeutic to the eye through a distal end of a delivery mechanism. A system control is configured to determine a position of the distal end of the delivery mechanism and control the therapeutic delivery system according to at least the determined position.

Claims (24)

1. A method for image-guided delivery of a therapeutic to an eye comprising:

generating at least one optical coherence tomography (OCT) image of the eye;

determining a position of a distal end of a therapeutic delivery mechanism from the at least one OCT image of the eye;

delivering the therapeutic to the eye through the therapeutic delivery mechanism according to the determined position of the distal end of the therapeutic delivery mechanism;

monitoring the delivery of the therapeutic from the at least one OCT image; and

controlling the therapeutic delivery system according to the at least one OCT image.

2. The method of claim 1 , wherein monitoring the delivery of the therapeutic from the at least one OCT image comprises determining an amount of the therapeutic delivered to the eye, and controlling the therapeutic delivery system comprises stopping delivery of the therapeutic when a desired dosage is achieved.

3. The method of claim 2 , wherein monitoring the delivery of the therapeutic from the at least one OCT image further comprises measuring leakage of the delivered therapeutic from a site of delivery.

4. The method of claim 1 , wherein monitoring the delivery of the therapeutic from the at least one OCT image comprises measuring one of stress and strain on tissue layers of interest.

5. The method of claim 4 , wherein controlling the therapeutic delivery system comprises determining a delivery speed for the therapeutic delivery system from the measured one of stress and strain.

6. The method of claim 1 , wherein monitoring the delivery of the therapeutic from the at least one OCT image comprises measuring a flow velocity of the delivered therapeutic.

7. The method of claim 1 , wherein determining a position of a distal end of a therapeutic delivery mechanism from the at least one OCT image of the eye comprises determining a set of boundaries for tissue layers within the eye, and delivering the therapeutic to the eye through the therapeutic delivery mechanism according to the determined position of the distal end of the therapeutic delivery mechanism comprises instructing the therapeutic delivery system to deliver the therapeutic when the distal end is within a desired tissue layer.

8. A method for image-guided delivery of a therapeutic to an eye comprising:

generating at least one optical coherence tomography (OCT) image of the eye;

determining a position of a distal end of a therapeutic delivery mechanism from the at least one OCT image of the eye;

delivering the therapeutic to the eye through the therapeutic delivery mechanism according to the determined position of the distal end of the therapeutic delivery mechanism;

monitoring the delivery of the therapeutic to a target area representing a biological area of interest from the at least one OCT image; and

controlling the therapeutic delivery system according to the monitored delivery.

9. The method of claim 8 , wherein monitoring the delivery of the therapeutic from the at least one OCT image comprises determining an amount of the therapeutic delivered to the eye, and controlling the therapeutic delivery system comprises stopping delivery of the therapeutic when a desired dosage is achieved.

10. The method of claim 9 , wherein monitoring the delivery of the therapeutic from the at least one OCT image further comprises measuring leakage of the delivered therapeutic from a site of delivery.

11. The method of claim 8 , wherein monitoring the delivery of the therapeutic from the at least one OCT image comprises measuring one of stress and strain on tissue layers of interest.

12. The method of claim 11 , wherein controlling the therapeutic delivery system comprises determining a delivery speed for the therapeutic delivery system from the measured one of stress and strain.

13. The method of claim 8 , wherein monitoring the delivery of the therapeutic from the at least one OCT image comprises measuring a flow velocity of the delivered therapeutic.

14. The method of claim 8 , wherein determining a position of a distal end of a therapeutic delivery mechanism from the at least one OCT image of the eye comprises determining a set of boundaries for tissue layers within the eye, and delivering the therapeutic to the eye through the therapeutic delivery mechanism according to the determined position of the distal end of the therapeutic delivery mechanism comprises instructing the therapeutic delivery system to deliver the therapeutic when the distal end is within a desired tissue layer.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 24, 2020
From: CLEVELAND CLINIC FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052003/0183 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2019
From: SRIVASTAVA, SUNIL K.; EHLERS, JUSTIS P.; TAO, YUANKAI K.
To: THE CLEVELAND CLINIC FOUNDATION
Reel/Frame 049391/0962 →
Continuity (3)
Division 14886428 · Oct 19, 2015
Provisional Application 62065444 · Oct 17, 2014
Related Publication 20190231591A1 · Aug 1, 2019